Pfizer, Allergan terminate merger after U.S. targets tax loophole
Wednesday, April 6, 2016 - 06:30
in Earth & Climate
Andrew V. PestanoWASHINGTON, April 6 (UPI) -- Pfizer and Allergan have abandoned a $152 billion merger due to U.S. government actions attempting to close a tax loophole known as corporate inversions.